A Prospective, Multicenter, Evaluator-Blind, Randomized, Comparator-Controlled Study of Belotero Intense (+), a Hyaluronic Acid Filler With Lidocaine, for Lip Augmentation
Aesthetic Surgery Journal · 2026
DOI: 10.1093/asj/sjag200 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Surgery Journal, 2026. Verfasst von Amir Moradi und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyaluronic Acid, Lidocaine, Dermal Fillers, Lip Augmentation. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Merz North America, Inc..
Abstract (Originalsprache)
Background
Lip augmentation with hyaluronic acid (HA)–based dermal fillers is commonly performed to enhance lip volume, shape, and symmetry.
Objectives
The aim of this study was to establish the safety and effectiveness of Belotero Intense with lidocaine (BIL), a cohesive polydensified matrix HA filler, for lip augmentation, and demonstrate its noninferiority to Restylane Silk with lidocaine (RSL), a US FDA-approved HA filler.
Methods
Patients with a Merz Lip Fullness Assessment Scale (MLFAS) rating of very thin, thin, or medium on upper and lower lips (Fitzpatrick skin type [FST] I-IV) or at least one lip (FST V or VI) were randomized 3:1 to receive BIL or RSL at baseline. Touch-up treatment was allowed at Week 4; retreatment at Week 48 was offered to BIL patients only. Primary effectiveness was assessed by a blinded evaluator using the MLFAS, and adverse events (AEs) were recorded up to 60 weeks.
Results
Belotero Intense with lidocaine achieved a Week 8 MLFAS-responder rate of 91.1% (144/158; 95% CI, 85.6-95.1), with the lower limit of the CI exceeding the prespecified 50% success criterion. The least squares mean difference in change from baseline vs RSL was 0.1 (95% CI, 0.0-0.3), meeting the prespecified noninferiority criterion (ie, lower CI limit >−0.5). Among Week 8 responders, 70/137 (51.1%) maintained improvement through Week 48 (post hoc analysis). No severe or serious related treatment-emergent AEs or unexpected AEs were reported.
Conclusions
Belotero Intense with lidocaine is a safe and effective treatment for lip augmentation in patients with upper and/or lower lip volume deficits. Level of Evidence: 1 (Therapeutic)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- Merz North America, Inc.
Zitieren
APA
Moradi, A., Gold, M. H., Hill, D., Dersch, H., Radusky, R., & Schwab, U. (2026). A Prospective, Multicenter, Evaluator-Blind, Randomized, Comparator-Controlled Study of Belotero Intense (+), a Hyaluronic Acid Filler With Lidocaine, for Lip Augmentation. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjag200
Vancouver
Moradi A, Gold MH, Hill D, Dersch H, Radusky R, Schwab U. A Prospective, Multicenter, Evaluator-Blind, Randomized, Comparator-Controlled Study of Belotero Intense (+), a Hyaluronic Acid Filler With Lidocaine, for Lip Augmentation. Aesthetic Surgery Journal. 2026. doi:10.1093/asj/sjag200
BibTeX
@article{Moradi2026,
author = {Moradi, Amir and Gold, Michael H and Hill, David and Dersch, Hanna and Radusky, Ross and Schwab, Ute},
title = {A Prospective, Multicenter, Evaluator-Blind, Randomized, Comparator-Controlled Study of Belotero Intense (+), a Hyaluronic Acid Filler With Lidocaine, for Lip Augmentation},
journal = {Aesthetic Surgery Journal},
year = {2026},
doi = {10.1093/asj/sjag200}
}
EUVIMED